BeiGene, Ltd. (HKG:6160)
134.40
+6.60 (5.16%)
May 13, 2025, 2:45 PM HKT
BeiGene Employees
BeiGene had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
2.95M HKD
Profits / Employee
-277.52K HKD
Market Cap
196.20B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Innovent Biologics | 5,659 |
Alibaba Health Information Technology | 1,435 |
Akeso | 2,778 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Sino Biopharmaceutical | 24,379 |
BeiGene News
- 4 days ago - BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit - Seeking Alpha
- 5 days ago - BeiGene targets $4.9B-$5.3B revenue for 2025 with strong BRUKINSA and pipeline growth - Seeking Alpha
- 5 days ago - BeiGene, Ltd. (ONC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat - Benzinga
- 5 days ago - BeiGene reports mixed Q1 results; reaffirms FY25 outlook - Seeking Alpha
- 5 days ago - Earnings Scheduled For May 7, 2025 - Benzinga
- 6 days ago - BeiGene Q1 2025 Earnings Preview - Seeking Alpha
- 13 days ago - U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene - Business Wire